Lmf Acquisition Opportunities Inc LMAO
We take great care to ensure that the data presented and summarized in this overview for LMF Acquisition Opportunities Inc is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in LMAO
Top Purchases
Top Sells
About LMAO
LMF Acquisition Opportunities, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Tampa, Florida.
Insider Transactions at LMAO
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2025
|
Jennifer A Baird Director |
BUY
Open market or private purchase
|
Direct |
4,200
+10.4%
|
$0
$0.24 P/Share
|
|
Dec 09
2025
|
Michael Messinger Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
14,500
+45.31%
|
$0
$0.35 P/Share
|
|
Aug 27
2025
|
Kenneth Van Heel |
BUY
Open market or private purchase
|
Direct |
10,000
+16.84%
|
$0
$0.86 P/Share
|
|
Aug 26
2025
|
Kenneth Van Heel |
BUY
Open market or private purchase
|
Direct |
25,000
+38.82%
|
$0
$0.89 P/Share
|
|
Aug 22
2025
|
Kevin Chung Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+14.67%
|
$0
$0.8 P/Share
|
|
Jul 10
2025
|
Kenneth Van Heel |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+21.74%
|
-
|
|
Jul 10
2025
|
Bernadette N Vincent |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+25.0%
|
-
|
|
Jul 10
2025
|
John Neuman |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+4.17%
|
-
|
|
Jul 10
2025
|
Jennifer A Baird Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+11.11%
|
-
|
|
Jul 01
2025
|
Eric Schlorff Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,667
+18.03%
|
-
|
|
Jul 01
2025
|
Kevin Chung Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.4%
|
-
|
|
Jun 30
2025
|
Jennifer A Baird Director |
BUY
Open market or private purchase
|
Direct |
10,000
+26.32%
|
$0
$0.42 P/Share
|
|
Jun 24
2025
|
John Neuman |
BUY
Open market or private purchase
|
Direct |
40,000
+33.33%
|
$0
$0.36 P/Share
|
|
Jun 04
2025
|
Kenneth Van Heel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+27.78%
|
-
|
|
Jun 04
2025
|
Bernadette N Vincent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,667
+25.0%
|
-
|
|
Jun 04
2025
|
John Neuman |
BUY
Exercise of conversion of derivative security
|
Direct |
2,667
+2.94%
|
-
|
|
Jun 04
2025
|
Jennifer A Baird Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,667
+12.9%
|
-
|
|
May 20
2025
|
Jennifer A Baird Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$10,000
$1.28 P/Share
|
|
May 20
2025
|
Kevin Chung Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
4,500
+19.84%
|
$4,500
$1.25 P/Share
|
|
Dec 11
2024
|
John Neuman |
BUY
Open market or private purchase
|
Direct |
10,000
+20.0%
|
$20,000
$2.04 P/Share
|
Last 12 Months Summary
Buy / Acquisition
183K
Shares
From
15
Insiders
| Open market or private purchase | 128K shares |
|---|---|
| Grant, award, or other acquisition | 16K shares |
| Exercise of conversion of derivative security | 38.7K shares |
Sell / Disposition
0
Shares
From
0
Insiders